$2.72
-0.17-5.73%
Last update: Nov 6, 4:00 PM
NewcelX Ltd (NCEL) Stock Price, Quote, News & History
NCELNASDAQ
NewcelX submitted an FDA Pre-IND package for NCEL-101 to advance its type 1 diabetes treatment into human trials.
You can purchase shares of NewcelX (NASDAQ:NCEL) through any online brokerage.
Other companies in NewcelX’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
NewcelX has a consensus price target of $23.00.
The stock price for NewcelX (NASDAQ: NCEL) is $2.34 last updated November 5, 2026 at 8:29 AM EST.
There are no upcoming dividends for NewcelX.
NewcelX does not have any upcoming earnings scheduled.
There is no upcoming split for NewcelX.
NewcelX is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional...
